More From Our Sponsor:
Powers Law Firm

SPONSORED CONTENT

340B program compliance seems to become more complicated each year, with new reporting obligations, scrutiny and expectations. Even seasoned 340B program health center staff can feel overwhelmed by the volume and pace of developments in the

SPONSORED CONTENT

Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need to protect themselves from the problem of duplicate discounts.  Federal law affords such protection for drugs dispensed or administered

SPONSORED CONTENT

The Supreme Court recently upended a cornerstone of administrative law, known as “Chevron deference,” in Loper Bright Enterprises v. Raimondo. A major question for 340B stakeholders is how the Loper decision will impact the 340B program. 

Although the Loper decision

SPONSORED CONTENT

Powers Law Firm is proud to support an unparalleled learning opportunity for 340B grantees.  The 340B Grantees Fall Conference, hosted by Ryan White Clinics for 340B Access, the National Association of Community Health Centers, and the State and

SPONSORED CONTENT

This past November, the 340B program celebrated its 30th anniversary—a huge milestone and a reason to rejoice and reflect. We are dismayed, however, that certain drug manufacturers are trying to revise the 340B program’s past and reimagine its future. More than 20 drug manufacturers have